[Secondary hyperuricemia in hematologic disease].
Inai
Kunihiro
K
Second Department of Pathology, Fukui Medical University, School of Medicine.
Tsutani
Hiroshi
H
D000493:Allopurinol / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000150:complications* / Q000378:metabolism; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy / Q000209:etiology*; D014503:Urate Oxidase / Q000627:therapeutic use; D014527:Uric Acid / Q000378:metabolism; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D004791:Enzyme Inhibitors; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase; D014503:Urate Oxidase